How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions ...
Investors in Caladrius Biosciences, Inc. CLBS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $2.00 Put had some of the highest ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Caladrius Biosciences, Inc. (NASDAQ: CLBS) and Cend Therapeutics, Inc. is fair to ...
Caladrius Biosciences stock was last seen 10.3% higher at $5.55, after the company said it bought the exclusive license to Shire's (SHPG) cell therapy program to treat refractory angina. CLBS shares ...
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results